Company Filing History:
Years Active: 1997-2003
Title: Inventor Spotlight: Jo Ann Hoskins
Introduction
Jo Ann Hoskins, a prominent inventor based in Indianapolis, IN, has made significant contributions to the field of biotechnology through her innovative research and development. With 17 patents to her name, she has demonstrated a remarkable ability to create solutions that have the potential to impact various scientific domains.
Latest Patents
Among her latest patents, Jo Ann has developed groundbreaking inventions such as the "Penicillin Binding Protein from Streptococcus pneumoniae." This invention provides isolated nucleic acid compounds encoding a novel high molecular weight penicillin-binding protein (PBP). Additionally, it includes vectors and transformed heterologous host cells for expressing the PBP, along with methods for identifying compounds that bind to and inhibit the enzymatic activity of the PBP.
Another noteworthy patent is the "Streptococcus pneumoniae Gene Sequence for DNA Ligase." This innovation also involves isolated nucleic acid compounds, this time encoding a DNA ligase. The patent further elaborates on vectors and transformed host cells for expressing this encoded protein, as well as methods to identify compounds that interact with and inhibit the protein's activity.
Career Highlights
Jo Ann currently works at Eli Lilly and Company, where her expertise is instrumental in advancing the company’s research initiatives. Her commitment to innovation and scientific excellence has positioned her as a key player in the pharmaceutical industry.
Collaborations
Throughout her career, Jo Ann has collaborated with esteemed colleagues, including Paul Luther Skatrud and Robert Brown Peery. These partnerships have fostered an environment of creativity and teamwork, contributing to the successful development of several impactful inventions.
Conclusion
Jo Ann Hoskins is a remarkable inventor whose work continues to push the boundaries of biotechnology. Her numerous patents and collaborative efforts at Eli Lilly and Company underscore her dedication to innovation in the scientific community. With her ongoing contributions, Jo Ann remains a vital figure in the pursuit of advancing medical science and developing new therapeutic solutions.